Darktrace Share Discussion Threads

[crosswires] 07/3/2024 10:10

No way for £10 in 18 months (that market exuberance has been left behind now) but as Tom says this is a solid LT play now, and you always have the bonus that it may get taken out in the meantime. Hard to see there being much downside risk as growth will likely continue in this range for a while yet.

[goggin] 07/3/2024 09:56

Positive, definitely now only a matter of time, 18 month, recovery in ft250 and we're over 10£ again. Expect plenty of short term volatility

[premium beeks] 07/3/2024 09:56

This thread is hilarious!

[villarich] 07/3/2024 09:32

We're off to the races! Watching the shorts burn baby burn!!

[tomduck] 07/3/2024 09:07

Imo hedge funds and shorters in general tend to stick to their initial thoughts longer than they should, even when they can see they are probably wrong.

They don’t like to admit they are wrong, and always think there is “no smoke without fire”, i’m afraid sometimes there is no fire.

[dealy] 07/3/2024 08:47

Hedge fund scum were spreading lies about this company 12 months ago. Glad to see them getting shafted

[tomduck] 07/3/2024 08:23

Shorts almost always have no clue, occasionally they get lucky but most are sheep reposting things they “heard” behind the school bike shed ;)

DARK is a great LT hold, sure it may get taken over but imo in 5 years will be over £10.

[villarich] 07/3/2024 08:14

I'm more of an MOT - Mocker Of Trolls :-)

[apotheki] 07/3/2024 08:10

Ok fair enough villa rich - my apologies and I am glad that you are NOT one of those 'horrible little sh*ts of a TROLL

[villarich] 07/3/2024 08:09

You all claim to be clever people but can't follow a thread. Maybe look at who I was replying to.

[villarich] 07/3/2024 08:07

Seriously? Are we going through this again? I'm a long term holder, my post is sarcastic. Get a grip

[apotheki] 07/3/2024 08:00

Villarich = more like yet another TROLL....ZZZZzzzz....

[villarich] 07/3/2024 07:57

DaRkTrAcE, mOrE lIkE rEtRaCe LoLzzzzzz

[apotheki] 07/3/2024 07:50

Poppy Gustafsson, CEO, said:

"Following the impact in the first quarter of our significant Go-to-Market changes, I was very pleased to see the team adapt quickly, delivering significantly improved second quarter sales, which enabled our strong financial performance in the first half of the year.

At the start of this financial year, we characterised our FY 2024 expectations as first half stabilisation and second half re-acceleration, and performance indeed stabilised in our second quarter. Now, it is the improvement in early cycle operating measures that underpins our confidence in a return to net new business growth in the second half. We see progress in longer cycle initiatives such as large strategic, channel and government pipeline development, and upsell momentum continues. In addition, ramped salesperson tenure has lengthened, increasing by 28%, including a 31% increase in our key North American markets. Our conversion rate also rose, again driven by noticeable improvements in North America, as more tenured salespeople followed a more disciplined process to pursue better targeted and qualified sales prospects.

We continue to see the cyber-crime landscape evolve rapidly in a challenging geopolitical environment and as the availability of generative AI tools lowers the barrier to entry for hostile actors. Against this backdrop and in the period ahead, we are preparing to roll out enhanced market and product positioning to better demonstrate how our unique AI can help organisations to address novel threats across their entire technology footprint."

[apotheki] 07/3/2024 07:40

FY 2024 Outlook (Unaudited)

Darktrace raised certain expectations for the current financial year on 11 January 2024, in its 1H FY 2024 trading update. As results for January and February were largely in line with these expectations, it is reiterating the FY 2024 guidance and related commentary it provided for ARR and Net ARR added. Darktrace is, however, now increasing its expectation for FY 2024 Revenue and Adjusted EBITDA margin.

Darktrace now expects FY 2024 Revenue growth of between 23.5% and 25.0% (previously 23.0% and 24.5%), reflecting continued strong ARR to revenue conversion and a relatively stable exchange rate environment.

Further, as Darktrace continues to control its discretionary spending without sacrificing planned investment, it is increasing its expectations for its FY 2024 Adjusted EBITDA margin to at least 21.0%, above its previous range of between 18.0% and 20.0%. Darktrace also confirms its guidance for Free cash flow (FCF) in the range of 50% to 60% of a now increased Adjusted EBITDA expectation. This lower-than-typical conversion range reflects the temporary impact to FCF from transitioning to new commission payout schedules at the start of FY 2024, reflecting a period in which Darktrace pays out both all new commissions earned and second half commission schedules from FY 2023. This impact is expected to be largely confined to FY 2024 and early FY 2025. Beyond this transitionary phase, Darktrace continues to expect its typical FCF conversion to fall in the range of 100% of Adjusted EBITDA, plus or minus 20 percentage points.

[scepticalinvestor] 07/3/2024 07:37

Back to 600p

[longtallsally] 06/3/2024 14:03

Retrace more like Darktrace

[millennialinvestor] 06/3/2024 09:21

Darktrace, more like retrace.

[apotheki] 05/3/2024 10:15

It is a TROLL as per other threads. Anyway back to DARK my money is on a TAKE OVER at some point within the next year or so. Any thoughts on this point of view?

[crosswires] 05/3/2024 10:13

Halfpenny is a typical message board loser, bashing things for whatever reason, probably not even short just too much time on their hands until they get the social

[buoycat] 04/3/2024 18:51

Hardly. They are trapped in a narrow range and could break out either way. Are you short by any chance?

[halfpenny] 04/3/2024 17:47

Dark days ahead we test 300p then 250p....not long to wait..

[goggin] 28/2/2024 00:22

Who would they be a good fit for? Would need 2 - 3 interested parties to push that price north of £6 in the short term. 10 tears from today, they will look very cheap